Chronos Archive seal

Review checklist: Voltaire (HR-EN002)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the choice of squamous cell carcinoma, the decision against prostate biopsy, the choice of weekly palliative radiotherapy over cystectomy or trimodality therapy, the catheter and voiding-trial plan, the catheter-associated infection treatment, and the opioid plan.
provenance reviewnot_startedBritannica, the Voltaire Foundation, his 1723 letter on smallpox (Wikisource), Lachèvre's 1908 edition with Wagnière's account and the 1778 autopsy report (Internet Archive), a 1970 review of Orieux's biography (Persée), an OUP blog, and the 2025 BJU International record (title only) logged.
safe messaging reviewnot_startedNo behavioral-health diagnosis; the documented opium overdose is flagged sensitive and informs the opioid plan; death recorded without graphic detail; legends about his deathbed are not repeated.

Judgment calls (dossier editorial resolutions)

  1. Name. He was born François-Marie Arouet and took the name Voltaire in 1718; he signed, published, and was known by it for sixty years. The display name is “Voltaire”, and `identity.name_parts` places that single name in the family-name field with an empty given array, as other single-name records do, so that C-CDA and FHIR do not split it or substitute a birth name he did not use. The birth name “François-Marie Arouet” is recorded as the alias; grep found it in no other record. The notes call him Voltaire, without “Mr.”
  2. Calendar and dates. France used the Gregorian calendar throughout his life, so no conversion is needed. His birth certificate gives 21 November 1694, which the record uses; his own repeated claim of 20 February is recorded as a conflicting alternative. The synthetic date of birth is November 21, 1942, so the whole-year shift is 248 years and 2026 maps to 1778.
  3. Index age and dates; a compressed schedule. The episode presents him at 83, in Paris, on April 6, 2026 (true frame 6 April 1778): after his return to Paris (10 February), the bleeding from the mouth and nose (25 February), and his acclaim at the Académie (30 March), and before the documented terminal illness of mid-May. Every visit had to fall before his death on 30 May 1778, and none was placed after he took to his bed (about 13 May), so the whole episode runs over one month: index April 6; CT urography April 8; focused visit and urology consultation April 13 (true 13 April); resection April 15; sick visit April 20; focused visit April 22; wellness visit April 28; radiotherapy from April 29; last focused visit May 6 (true 6 May 1778). The full visit structure fits: three chronic-care visits, a sick visit, a wellness visit, and the consultation at visit 2. Goal target dates were set no later than May 27. Radiotherapy is recorded as in progress after two of six fractions; its planned completion would fall after his true death date and is not recorded.
  4. Presenting problem and diagnosis. The intake problem is gross hematuria with difficult urination (R31.0), resolved on April 22, 2026, when the resection pathology gives the diagnosis. Chronic retention (R33.8) and acute kidney injury from obstruction (N17.9, resolved at visit 2) are known at intake. Benign prostatic hyperplasia (N40.1) is recorded at visit 2 and the bladder cancer (C67.4) at visit 3. Intake documents show only what was known at intake.
  5. Which diagnosis, and why. The 1778 autopsy describes a bladder more than an inch thick at its upper and posterior part, lard-like, with suppurating tubercles leaking into the abdomen, and a very large, entirely hard prostate (D). The most recent peer-reviewed reading (Charlier and colleagues, BJU International, 2025) is a perforated squamous cell carcinoma of the bladder; Britannica gives uremia; prostate cancer is also suggested by the “scirrhous” prostate, though no reputable source read argues it. The modern episode follows the bladder evidence: a muscle-invasive, keratinizing squamous cell carcinoma of the posterior wall and dome (cT3b N0 M0), with benign prostatic hyperplasia and chronic retention, and it deliberately does not diagnose prostate cancer (PSA 6.4 ng/mL with a PSA density of 0.08 and a smooth gland; no MRI or biopsy by shared decision, because the finding would not change care at 83). The historical cause of death remains R, disputed (CLM-0012); the record asserts none as his historical diagnosis. The 2025 article could not be read (no abstract; publisher page blocked); only its title and bibliographic data are used. Pure squamous cell carcinoma is uncommon where schistosomiasis is not endemic; the record states this and lists the risk factors that were asked about and absent, and does not invent bladder stones.
  6. Treatment choice. After a geriatric assessment (G8 11 of 17, BMI 18.5, independent in self-care, needing help with shopping and travel), cystectomy, daily bladder-preserving radiotherapy, weekly palliative radiotherapy, and symptom care were discussed. He chose weekly hypofractionated radiotherapy, 36 Gy in six fractions (the regimen of Hafeez and colleagues for patients unsuitable for radical treatment), with early palliative care, because his goals were to stay at home, keep writing, and avoid long hospital stays. No chemotherapy is given, because squamous histology responds poorly and his kidney function and frailty argue against it.
  7. Opium, opioids, and the medication review. Accounts agree that he took a large dose of an opium preparation in mid-May 1778 (CLM-0008, D, sensitive), after the index date. The modern episode does not place that event in his past; it echoes it only in the safety plan: a friend's offer of opium drops is refused, and the clinic prescribes scheduled acetaminophen with oxycodone 2.5 mg as needed (no more than three doses a day, 15 tablets, one prescriber), naloxone, senna, a prescription monitoring program check, a locked box, and review in two weeks (CDC 2022). The intake medication review stops a nightly diphenhydramine sleep aid, which can cause retention (AGS Beers 2023), and over-the-counter sodium phosphate enemas, which are unsafe with reduced kidney function; these echo his documented self-medication and purges without asserting them.
  8. What was verified and what was not. Smallpox with onset on 4 November 1723 is D from his own letter; the OUP blog's “December 1723” is the date of the letter, and the brief's “November 1723” is correct. The bleeding of 25 February 1778, strangury with catheterization, the opium episode, and the autopsy findings are D from Lachèvre's 1908 edition. Lachèvre's main text is an anonymous, hostile manuscript; its coffee anecdote (eighteen cups) is graded R, possible, and the roster's “40 to 50 cups a day” was not found and is left out. The roster's “probable IBD”, “anxiety”, and “insomnia” were not found in any reputable source read and are not used; chronic constipation is the modern echo of the documented colic, purges, and enemas. Legends about his deathbed, which Britannica calls fabricated, are not repeated. The Britannica pages could be read only by direct download (WebFetch was refused).
  9. The bleeding from the mouth and nose. The source of the documented bleeding of February 1778 is unknown. The modern episode records it in the referral as a nosebleed with blood in the mouth after a coughing fit, treated with packing, and the intake CT includes the chest, which is clear (as the autopsy found the chest healthy and the vessel healed). This is a synthetic reading that asserts nothing about the 1778 event.
  10. Sick and wellness visits. The sick visit is a febrile catheter-associated urinary tract infection with Escherichia coli five days after the resection, treated with a catheter change and seven days of cefpodoxime (IDSA); it fits his catheter and echoes, without asserting, the infected urine described in his last weeks. The wellness visit is `annual_wellness_subsequent` at 83, with PHQ-2, Mini-Cog, Timed Up and Go, a falls and nutrition plan, vaccines up to date, cancer screening stopped, and advance care planning (a health care agent and a portable medical order) that names no real person.
  11. Focused visits. The three chronic-care follow-ups (one, two and a half, and four and a half weeks after intake) are documented as focused visits on the AUA/SUFU hematuria guideline, the CMID BPH and urologic cancer monographs, the AUA BPH guideline, NCCN, AUA/ASCO/SUO and EAU bladder cancer guidance, ASCO geriatric oncology, IDSA, and the CDC opioid guideline: imaging, cystoscopy, culture and cytology, kidney function after drainage, PSA interpretation, IPSS and post-void residual (recorded as not indicated while the catheter was in), alpha-blocker tolerability, the geriatric assessment, staging, pain scores, opioid start and follow-up, radiation toxicity, and nutrition. The CMID surveillance schedules for NMIBC and after cystectomy are recorded as not indicated, with the reason. One deviation is recorded as `deferred`, with its outcome and corrective action, and no result was invented: home physical therapy ordered at the wellness visit had not started by the last visit because the agency had no therapist; he had not fallen, and a second agency was arranged with interim exercises.
  12. Consultation. The urology referral and consultation (Aurelio Bergström-Nwosu, MD, a fictional consultant, on the day of the second visit) are S. The consultant performs cystoscopy, finds a solid tumor likely to be muscle-invasive, advises resection under anesthesia, keeps the catheter until then with a later voiding trial on tamsulosin, advises against prostate MRI or biopsy, and frames the treatment options for after the pathology; the record then shows the resection, the voiding trial passed, no prostate biopsy, and the geriatric assessment and treatment choice.
  13. Real people. Wagnière, Gaultier, Tronchin, Try, Richelieu, and the baron de Breteuil appear only in documented history claims. The modern episode names none of them and attributes no decision, statement, or health fact to them or to any relative; his assistant, the colleague he names as health care agent, and the friend who offers drops are unnamed and synthetic.
  14. Family and past history. Only his mother's death when he was seven and his putative father's occupation are recorded (causes not recorded in the cited sources). Past medical history holds smallpox (1723), lifelong digestive and urinary complaints, and the bleeding of February 1778, all before the true-frame index date. The opium dose, strangury, uremia, death, and autopsy appear only on the timeline after the index date.
  15. Primary clinician. Honorine Delacroix-Mensah, MD, is cast as his primary care physician.
  16. Voltaire died in 1778, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-05-06
Progress note 06 (C-CDA)
Home physical therapy for strength and balanceWithin one to two weeks of the falls assessmentMissed: home physical therapy ordered at the wellness visit has not started because the agency had no therapist free. No harm: he has had no falls. Corrective action: the clinic arranged a second agency, which will visit this week, and gave him a printed set of chair exercises in the meantime

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-04-22
Progress note 04 (C-CDA)
ReferralRadiation oncology and palliative careReferredPlanning scan and the first fraction next week; palliative care home visit within two weeks
2026-04-28
Progress note 05 (C-CDA)
PreventionFalls preventionReferredHome physical therapy for strength and balance; night light and urinal

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0007An anonymous and hostile manuscript account of 1778, published by Frédéric Lachèvre in 1908, claims that in May 1778, before a meeting at the Académie, he secretly took as many as eighteen cups of coffee.possible
CLM-0012Retrospective readings of his final illness differ. A 2025 paleoproteomic study of blood residues by Charlier and colleagues concluded that he died of a perforated squamous cell cancer of the bladder with peritoneal extension; Britannica describes uremia; the autopsy's very large, hard prostate leaves prostate disease, benign or malignant, as a further possibility.disputed

Sensitive claims

ClaimGradeStatement
CLM-0008DIn mid-May 1778, according to Wagnière's account, he was persuaded to take a liquor brought by an apothecary and then, in great agitation, asked the maréchal de Richelieu to send him some of his prepared opium; one witness said he saw him finish the bottle. The anonymous manuscript says he took the whole vial at once instead of dividing it into three or four doses. Orieux's account has him refuse the apothecary's remedy and accept the opium preparation brought by Richelieu, after which he felt a trail of fire from throat to bowels and became frenzied.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-04-06Urine red cells75 /[HPF] (high)High
2026-04-06Urine white cells8 /[HPF] (high)High
2026-04-06Post-void residual (bladder scan)460 mL (high)High
2026-04-06Hemoglobin11.6 g/dL (low)Low
2026-04-06Bicarbonate21 mmol/L (low)Low
2026-04-06BUN34 mg/dL (high)High
2026-04-06Creatinine1.68 mg/dL (high)High
2026-04-06eGFR40 mL/min/1.73 m² (low)Low
2026-04-06PSA6.4 ng/mL (high)High
2026-04-13Hemoglobin11.2 g/dL (low)Low
2026-04-13eGFR58 mL/min/1.73 m² (low)Low
2026-04-20Urine white cells60 /[HPF] (high)High
2026-04-20White blood cells12.6 10*3/uL (high)High
2026-04-20eGFR53 mL/min/1.73 m² (low)Low
2026-04-22Hemoglobin10.9 g/dL (low)Low
2026-04-22eGFR59 mL/min/1.73 m² (low)Low
2026-04-22Post-void residual (bladder scan)140 mL (high)High
2026-05-06Hemoglobin10.8 g/dL (low)Low
2026-05-06Post-void residual (bladder scan)120 mL (high)High